Fresenius 2Q net falls 2% to euro110 million


FRANKFURT: German medical company Fresenius SE said Tuesday its net profit fell 2 percent on one-time effects despite improved sales during the second quarter.

The Bad Homburg-based company earned euro110 million ($157.3 million) in the April-June period compared with euro112 million a year earlier.

The dip was blamed on costs related to its acquisition of APP Pharmaceuticals and accounting for an exchangeable bond.

Sales rose 21 percent to euro3.5 billion compared with euro2.9 billion a year earlier.

Fresenius provides products and services for hospital and out-patient care and specializes in dialysis treatments. - AP

Latest business news from AP-Wire

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

Next In Business News

Press Metal posts steady Q3 profit on favourable pricing
TH Plantations to complete sale of assets over next 12 months
Bitcoin plummets to 10-day low, dragging smaller cryptocurrencies down
IHH net profit bounce back thanks to patient volume recovery�
YTL Power posts higher Q1 net profit
Higher volume and better products mix lift JCY earnings�
Market jumps after Budget passed in parliament
Evergrande Property's Hong Kong IPO meets with lukewarm reception, raises US$1.8bil
Southeast Asia IPO proceeds buck downtrend to hit US$6.4bil as of mid-Nov
Japan shares end at over 29.5-year high as Nasdaq gains cheer tech stocks

Stories You'll Enjoy